ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.661,51
0,54%
Dow Jones
40.888,54
1,68%
Euro vs US Dollar
1,08932
-0,06%
Bitcoin
64.656,15
-0,30%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

  7. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DatumZeitQuelleÜberschriftSymbolFirma
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
16/02/201020h36Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
16/02/201020h28Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
16/02/201019h45Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
11/02/201019h54Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
04/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals Announces Conference Call and WebcastNASDAQ:ANPI
25/01/201017h51Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/12/200923h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/12/200923h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/12/200922h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/12/200922h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/12/200922h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/11/200923h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
12/11/200923h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/11/200923h23Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/11/200921h01Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/11/200913h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009NASDAQ:ANPI
23/10/200915h00PR Newswire (US)Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United StatesNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
19/10/200922h30PR Newswire (US)Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submissionNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
15/10/200923h27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
12/10/200913h02MarketwiredAnalystChoice.com Brings You the Best Complimentary Research Report on ASTM, CEGE, LINTA, AMSC, OCNF and ANPINASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/10/200918h35PR Newswire (US)Angiotech Pharmaceuticals, Inc. Announces Conference Call and WebcastNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
30/09/200920h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Kürzlich von Ihnen besucht

TG
432
Arbor Metals
TG
LHA
Deutsche Lufthansa
TG
ALV
Allianz
DBI
DAX
DAX
CCOM
US30
US 30
USOTC
BASFY
BASF (QX)
TG
DBK
Deutsche Bank
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
FX
EURJPY
Euro vs Yen
DBI
TDXP
Tec DAX
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten